Which GLP-1 does Humana prefer?

There is no universal favorite. In the 2026 plans we reviewed, Ozempic and Mounjaro were the most consistently listed for type 2 diabetes. Your exact plan decides, so check yours.

Does Humana cover Mounjaro?

Mounjaro is commonly listed for type 2 diabetes with prior approval and quantity limits, varying by plan. It is not a Bridge product, and it is not covered when used only for weight loss.

Does Humana cover Rybelsus?

Rybelsus (oral semaglutide for type 2 diabetes) appears on some Humana plans and not others, so it needs an exact-plan lookup. It is not covered for weight loss, and it is not a Bridge product.

Does Humana cover Trulicity?

Trulicity is a type 2 diabetes GLP-1 that appears on some Humana plans. Coverage, tier, and restrictions vary by plan -- check your specific drug list.

Does Humana cover Wegovy for weight loss?

Not on a standard plan for weight loss by itself. Wegovy injection or tablets may be Part D-coverable for the FDA-approved heart-risk indication if your exact plan lists and approves the form; Wegovy injection -- not the tablets -- may also be coverable for noncirrhotic MASH with F2-F3 fibrosis. For weight-loss-only use, look at the $50 Medicare Bridge.

Does Humana cover Zepbound?

On a standard plan, Zepbound may be Part D-coverable for moderate-to-severe sleep apnea in adults with obesity if your exact plan lists and approves it -- not for weight loss alone. On the Bridge, only the Zepbound KwikPen is included.

Does Humana cover Foundayo?

Foundayo is currently a Medicare Bridge product for eligible weight-loss use. That is not the same as it being on your Humana formulary -- check your plan separately for any other coverage.

Is the Medicare GLP-1 Bridge the same as Humana coverage?

No. Humana runs the processor that handles the claims, but CMS operates the Bridge outside your normal Part D coverage and payment. It is a government program, not a Humana benefit.

Can I appeal a Medicare GLP-1 Bridge denial?

No -- the Bridge has no appeals process. If the request had incorrect or incomplete information, your prescriber can resubmit corrected or added information. This is different from your regular Part D plan, which does have appeal rights.

Are Zepbound KwikPen needles covered by the Bridge?

No. Pen needles are bought separately and generally are not part of the $50 Bridge copay. Ask your pharmacy what they will cost.

How long does a Medicare GLP-1 Bridge approval last?

An approved Bridge request stays valid through December 31, 2027. You generally will not need a new one for refills unless you switch from one covered GLP-1 product to another.

How long do I have to appeal a Humana Part D denial?

Your denial notice states your exact deadline. Part D appeals have a firm window -- generally around 60 days to request the first level of appeal. Standard decisions usually come back within about 7 days; urgent ones within 72 hours. Do not miss the date on your notice.

Does being on Tier 3 guarantee coverage?

No. A listing is a starting point. Prior authorization, quantity limits, a valid diagnosis, and pharmacy rules can still apply.

Can I request a formulary exception?

Yes. If your drug is not listed, you and your prescriber can request a coverage exception with a supporting statement explaining the medical reason. Ask Humana for the exact process.

How often does Humana update its formulary?

Humana posts updates monthly, and coverage can change during the year under Medicare rules. That is exactly why we tell you to check your live plan before you fill.

What if I don't know which Humana plan I have?

Check your ID card, your MyHumana account, your Evidence of Coverage, or call the member number on your card -- before you rely on any general article, including this one.

Insurance guideVerified July 2026

Best GLP-1 on Humana Formulary in 2026: What’s Actually Covered

By The RX Index Editorial Team · Published July 15, 2026 · Last verified: July 15, 2026

Plus the separate $50 Medicare GLP-1 Bridge for eligible weight-management prescriptions.

Affiliate disclosure: Some links on this page are affiliate links, which means we may earn a commission if you use them. It costs you nothing extra, and it never changes the Humana documents, the coverage facts, or the conclusions below. We tell you plainly which links those are.

If you’re looking for the best GLP-1 on Humana formulary, here’s the honest bottom line: it depends on your exact plan, why the medicine is prescribed, and which form you’re getting. In the 2026 Humana Medicare drug lists we reviewed, Ozempic and Mounjaro showed up most consistently — for type 2 diabetes, with your plan’s approval first. For weight loss by itself, standard Medicare drug plans don’t cover GLP-1s. But a separate $50-per-month Medicare program now covers certain GLP-1s for eligible weight-management prescriptions, including Wegovy, Foundayo, and the Zepbound KwikPen.

And there’s a catch that trips people up: that $50 program is separate from your Humana plan, and it doesn’t include every version of Zepbound. We’ll show you exactly who it helps and who it leaves out.

A “formulary” is the list of drugs your plan covers. “GLP-1” is shorthand here for this family of medicines — including semaglutide drugs like Ozempic and Wegovy, and the dual GIP/GLP-1 drugs Mounjaro and Zepbound.

Which is the best GLP-1 on Humana formulary for your situation?

There’s no single winner for everyone. In the official 2026 Humana plans we reviewed, Ozempic and Mounjaro were the most consistent listings for type 2 diabetes. If you’re on Medicare and want a GLP-1 for weight loss only, a different set of drugs may be covered through the separate $50 Medicare GLP-1 Bridge. Here’s the quick version, by why you’re taking it:

Your situation	The first coverage path to check
Type 2 diabetes	Your exact Humana plan for Ozempic or Mounjaro — check that plan for prior authorization, diagnosis, and quantity-limit rules
Weight loss only, and you have Medicare	The $50 Medicare GLP-1 Bridge (Wegovy, Foundayo, or the Zepbound KwikPen)
Established heart disease + overweight or obesity	Standard Part D — check whether your exact plan lists and approves Wegovy
Moderate-to-severe sleep apnea + obesity	Standard Part D — check whether your exact plan lists and approves Zepbound
Noncirrhotic MASH liver disease with fibrosis	Standard Part D — check whether your exact plan lists and approves Wegovy injection
Humana through an employer, or Humana Medicaid	Your exact employer or state drug list — the Medicare rules above may not apply

This guide is for you if…

You have Humana and want to know which GLP-1 your plan will actually pay for
You’re weighing covered options like Ozempic and Mounjaro
You’re on Medicare and not sure if your prescription goes through your plan or the new $50 program

This guide is not for you if…

You want us to tell you which drug is medically best — only your clinician can do that
You need a guaranteed copay or a promise you’ll be approved — no honest page can give you that
You’re shopping for cash-pay compounded programs — that’s a separate topic

The RX Index

We’re the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation. The right GLP-1 provider isn’t the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred form (injection or oral), and your budget.

Check your Humana GLP-1 path →

Answer a few quick questions and we'll point you to the coverage path that fits your plan and diagnosis. No sign-up, no pressure.

✓ What we actually verified

On July 15, 2026, our editorial team reviewed Humana’s 2026 Medicare drug lists and coverage pages, the official CMS and Medicare.gov materials for the new GLP-1 Bridge, and current FDA prescribing information. We cross-checked the program’s cost and eligibility rules against KFF and AARP.

We did not log into your MyHumana account, guess your copay, or copy exact drug “tiers” from one plan onto another — because those change by plan and by month. Where the answer depends on your specific plan, we show you how to pull your own exact numbers. Sources are linked at the bottom.

Here’s the one honest thing we can’t do: we can’t tell you your exact copay, and we can’t promise you’ll be approved. Nobody who hasn’t seen your specific plan can. What we can give you is better: the exact path to check, the questions to ask, and a tool that maps your situation.

What are the three main ways to pay for a GLP-1 if you have Humana?

There are three main payment paths to check: your exact Humana benefit for an approved medical condition, the separate $50 Medicare GLP-1 Bridge for eligible weight-loss use, or paying cash. The reason it’s prescribed decides whether your Humana plan or the Bridge is the first system to check — and your exact plan, drug, and form decide whether the claim can go through.

This is the part almost every other page skips, and it’s the whole game. The brand name doesn’t decide how your prescription is paid for. The reason it’s prescribed does. Here’s the map — built from the official CMS rules and each drug’s FDA-approved uses:

Why the medicine is prescribed	First claim system to check	Why	Source
Type 2 diabetes	Your Humana plan (standard Part D)	Ozempic, Mounjaro, Rybelsus, and Trulicity are FDA-approved for type 2 diabetes and appear on Humana plans. They are not Bridge products.	FDA / CMS
Weight loss only	The $50 Medicare GLP-1 Bridge	The Bridge covers specific weight-loss GLP-1s for eligible Medicare members.	CMS
Heart-attack / stroke risk reduction (established heart disease + overweight or obesity)	Your Humana plan (standard Part D)	CMS routes this to your Part D plan, even if you’ll also lose weight. Wegovy is FDA-approved for this.	CMS / FDA
Moderate-to-severe sleep apnea + obesity	Your Humana plan (standard Part D)	This is a Part D lane, not a Bridge claim. Zepbound is FDA-approved for sleep apnea in adults with obesity.	CMS / FDA
Noncirrhotic MASH with F2–F3 fibrosis	Your Humana plan (standard Part D)	CMS treats this as a Part D condition. Wegovy injection — not the tablets — is FDA-approved for it.	CMS / FDA
Commercial Humana (through work)	Your exact employer/individual plan	The Medicare Bridge doesn’t apply. Your rules come from your employer’s benefit design.	—
Humana Medicaid	Your exact state’s drug list	Medicaid coverage is set state by state.	—

MASH — metabolic dysfunction-associated steatohepatitis, once called NASH — is an inflammatory fatty-liver disease. The Wegovy indication here is noncirrhotic MASH with F2–F3 fibrosis. Part D is Medicare’s prescription drug coverage.

Read that table twice. A neighbor with diabetes and you-with-weight-loss-goals can both ask “does Humana cover Ozempic?” and get completely different answers — because you’re walking through different doors. Get the door right first, and half the confusion disappears.

See which door fits your prescription →

Tell us your plan type and why the medicine is prescribed. We'll show you whether it belongs with your Humana plan, the $50 Bridge, or a cash-pay option.

Which GLP-1 medications appear on Humana’s 2026 formularies?

FDA approval can make a use eligible for Part D coverage, but it does not put a drug on every Humana plan. In the official 2026 Humana Medicare drug lists we reviewed, Ozempic and Mounjaro were the most consistent listings for type 2 diabetes. Rybelsus and Trulicity varied by plan, and Wegovy or Zepbound still require an exact-plan lookup. The tier, prior authorization, and quantity limits all depend on your specific plan.

Here’s the trap: “FDA-approved” and “on my Humana plan” are two different things. A drug can be FDA-approved for your condition and still not sit on your plan’s list — or sit there with rules attached. Don’t stop at “it’s approved.” Check your plan.

What to expect by plan type:

Plan type	Which GLP-1s usually show up	What to expect
Individual Medicare drug plans (standalone Part D)	Ozempic and Mounjaro most consistently, for type 2 diabetes; Rybelsus and Trulicity vary	Usually a brand tier with prior authorization and often a quantity limit
Medicare Advantage plans with drug coverage	Similar diabetes GLP-1s, plan by plan	Approval and limits are common; check the exact plan
Employer / group Medicare plans	Similar drugs, but placement can differ from individual plans	Group plans are designed by the employer, so tiers and rules may not match an individual plan
Humana Medicaid (state plans)	Set by each state's drug list	Varies by state — never assume one state's coverage applies to another

These reflect the Humana Medicare drug lists we reviewed and the common patterns across them. They are not a guarantee for your plan. Your current member drug lookup, your Evidence of Coverage, and your plan’s coverage decision are what actually control your benefit.

A quick word on the drugs themselves:

Ozempic and Mounjaro: For type 2 diabetes. The two we saw most consistently. Expect prior approval, and often a quantity limit. Not covered for weight loss alone.
Rybelsus: Oral (pill) semaglutide for type 2 diabetes. It shows up differently across plans, so check yours. FDA labeling notes that Rybelsus and Ozempic tablets aren't substitutable milligram-for-milligram, and switching from the Ozempic injection follows label-specific steps.
Trulicity: Another diabetes GLP-1 that appears on some Humana plans.
Wegovy: Wegovy injection may be Part D-coverable for its heart-risk or noncirrhotic MASH (F2-F3 fibrosis) indication if your exact plan lists and approves it. Wegovy tablets carry the heart-risk and weight-management indications, but not the MASH one. Not covered for weight loss alone on a standard plan.
Zepbound: May be Part D-coverable for moderate-to-severe sleep apnea in adults with obesity if your exact plan lists and approves it. Not covered for weight loss alone on a standard plan.

The catch that trips people up: a drug being “on the formulary” does not mean you’re approved. It means the drug is on the list. Depending on the plan, you may still have to clear prior authorization, quantity limits, a documented diagnosis, step therapy, or pharmacy rules. We’ll cover why claims still get denied — and what to do — a little further down.

What is the Medicare GLP-1 Bridge, and which drugs cost $50 per 30-day supply?

The Medicare GLP-1 Bridge is a CMS program that lets eligible Medicare members get certain GLP-1s for weight loss at a flat $50 per 30-day supply. It runs from July 1, 2026 through December 31, 2027. It covers all forms of Wegovy and Foundayo, plus the Zepbound KwikPen only. It operates outside your normal Part D coverage and payment — even though Humana helps run it behind the scenes.

This is the big 2026 news, and it’s the answer a lot of you are actually here for. Before the Bridge, prescriptions used only for weight loss sat outside standard Part D coverage, which left Medicare members paying another way. The Bridge changes that for now.

What the $50 covers — and what it doesn’t:

Drug	On the Bridge?	The detail that matters
Wegovy (injection and tablets)	Yes	All forms are included
Foundayo (orforglipron, tablets)	Yes	All current tablet forms included
Zepbound KwikPen	Yes	KwikPen only
Zepbound single-dose pen or vial	No	Not covered by the Bridge
Ozempic / Mounjaro	No	Not Bridge products. When prescribed for a covered condition like type 2 diabetes, submit them to your Part D plan and check the formulary

Foundayo is an FDA-approved oral GLP-1 for chronic weight management. A Zepbound KwikPen is a multi-dose prefilled pen — not the single-dose pens or vials. Pen needles are bought separately and generally aren’t part of the $50.

Who qualifies. You must meet all of these:

You’re enrolled in an eligible Medicare Part D plan — either a standalone drug plan or a Medicare Advantage plan with drug coverage (Special Needs Plans and employer/union group plans count too). You’re not eligible if your only Medicare coverage is a private fee-for-service plan, a cost plan, or a PACE program.
It’s prescribed for weight loss — to reduce and keep off excess weight, along with ongoing diet and activity changes, consistent with the drug’s FDA-approved label.
You meet the health rules, based on where you were when you started the medicine: a body mass index (BMI) of 35 or higher; or a BMI of 30+ with heart failure, uncontrolled high blood pressure, or chronic kidney disease; or a BMI of 27+ with prediabetes, a past heart attack, a past stroke, or symptomatic peripheral artery disease.
Your doctor sends a prior-approval request to a special CMS processor — a separate system from your plan’s normal pharmacy billing.

Confirm the fine print. CMS can update the exact eligibility criteria and the list of covered products during the program. Before you count on qualifying, check the exact rules on the CMS Medicare GLP-1 Bridge page the day your prior authorization goes in. We’d rather you check than get a surprise “no.”

The honest catches — please don’t skip these:

The copay is $50 for each eligible 30-day supply, and it does not rise with your dose. That predictability is genuinely good.
But that $50 does not count toward your Part D deductible or your yearly out-of-pocket cap. It sits outside your normal drug benefit.
Extra Help / the low-income subsidy does not lower it. If $50 a month is a stretch, this is a real problem, and it's okay to say so.
Coupons and manufacturer savings cards can't be applied to the $50 — and generally don't work for Medicare members anyway.
If the Bridge denies the request, there's no Bridge appeals process. Your prescriber can resubmit corrected or added information, but there's no formal appeal like there is with your regular plan.
An approved Bridge request stays valid through December 31, 2027. You generally won't need a new one for refills unless you switch from one covered GLP-1 to another.
It's temporary. CMS extended the Bridge after the Medicare Part D piece of a longer-term program (the BALANCE Model) didn't launch in 2027. Later Part D coverage is still possible after 2027 — but it's not guaranteed.

One more thing worth knowing: CMS selected Humana to run the central processor that handles the Bridge’s prior authorizations, claims, and pharmacy payments. Even so, the Bridge is not a Humana formulary benefit. Humana handling the paperwork doesn’t turn a government program into “Humana coverage.” Keep those two ideas separate and you’ll avoid a lot of confusion.

For scale: a KFF analysis of 2023 Part D data estimated about 3.8 million members could be eligible. The drugmakers agreed to a set net price of about $245 per month to Medicare — but eligible members still just pay the $50.

Standard Part D vs. the $50 Bridge, side by side

This is the distinction almost everyone gets tangled up in. Here’s the whole thing in one place — every row below is from CMS and Humana:

	Standard Part D (your Humana plan)	The $50 Medicare GLP-1 Bridge
Covers a GLP-1 for…	Approved conditions (diabetes, heart-risk, sleep apnea, MASH)	Weight loss only, if you’re eligible
Which drugs	Your plan’s listed GLP-1s (e.g., Ozempic, Mounjaro for diabetes)	Wegovy (injection + tablets), Foundayo (tablets), Zepbound KwikPen only
What you pay	Varies by plan, tier, and coverage stage	Flat $50 per 30-day supply
Counts toward your deductible?	May apply	No
Counts toward the 2026 $2,100 out-of-pocket cap?	Yes, for covered drugs	No
Does Extra Help lower it?	Can lower your costs	No
Need a Part D denial first?	N/A	No — you don’t need a denial to use the Bridge
If you’re denied, can you appeal?	Yes (Medicare appeal process)	No appeal — prescriber can resubmit corrected info
How long approval lasts	Per your plan	Through Dec 31, 2027 (unless you switch covered products)

Want the deep version? See our full Medicare GLP-1 Bridge guide and Bridge eligibility guide.

Find out if your prescription belongs in Part D or the $50 Bridge →

This is the single most common mix-up. We'll sort it for your exact situation.

Why does Humana say “no” even when the drug is on the formulary?

A formulary listing is not an approval. Your GLP-1 claim can still be denied because prior authorization wasn’t finished, the quantity is above the plan’s limit, the diagnosis code is missing, the exact product form isn’t listed, or the prescription was sent to the wrong system. Some of these are quick fixes; others reflect a condition or product your plan simply doesn’t cover. The rejection reason tells you which one you’re facing.

Getting denied feels like a wall. Sometimes it’s a missing-data snag; sometimes it’s a real exclusion. Here’s our plain-English decoder:

What you see or hear	What it usually means	Who fixes it	What to do
"Prior authorization required"	The drug is listed, but the plan hasn't approved your medical case yet	Your prescriber	Get the plan's exact criteria and send the records it asks for
"Quantity limit exceeded"	The amount or refill timing is above the plan's cap	Prescriber + pharmacy	Confirm the prescribed amount; ask if a quantity exception fits
Missing or invalid diagnosis code	The claim is missing an accepted diagnosis	Prescriber or pharmacy	Confirm the diagnosis code before resubmitting
"Not on formulary"	The exact brand or form isn't on the list	You + prescriber	Ask Humana for a covered alternative, or request a formulary exception
Weight-loss claim rejected by your plan	It may belong in the $50 Bridge, not standard Part D	Pharmacy + prescriber	Check the Bridge instead — you don't need a Part D denial first
The Bridge rejects it	Wrong product/form, or an eligibility or approval gap	Pharmacy + prescriber	Confirm the exact product form and Bridge criteria. If the request had wrong or missing info, the prescriber can resubmit — but the Bridge has no appeal
It's "covered" but still costs a lot	Tier, deductible, pharmacy, or coverage stage is driving the price	You + Humana	Get a member-specific price through MyHumana or by calling

Humana’s own drug guide is upfront about this: a listed drug can still carry prior authorization, quantity limits, and step-therapy rules. So a denial may be an appealable restriction — or it may be a real exclusion. The reason on your notice tells you which.

Build my plan-and-diagnosis prescriber checklist →

Tell us your plan and diagnosis, and we'll show you the records and questions your prescriber may need to verify, so you don't get bounced twice.

How do I check my exact Humana GLP-1 coverage before filling the prescription?

The only way to know your real coverage is to check the drug list tied to the exact plan on your member ID card. A general article can’t replace it. Before you pay for a visit, confirm the exact brand, form, tier, prior-authorization rule, quantity limit, and diagnosis — and get a member-specific price.

Here’s the exact five-minute process we’d use ourselves. Do this and you’ll walk into your doctor’s office knowing the current listing, the published restrictions, and the questions that still need an answer.

1
Find your exact plan. Look at your ID card. Are you on a standalone drug plan, a Medicare Advantage plan, an employer plan, or Medicaid? The plan name and ID matter more than "I have Humana."
2
Sign in to MyHumana (or use Humana's drug-list lookup). This beats any PDF because it's tied to your plan.
3
Search the exact product and form. Not just "semaglutide." Search the brand, the strength, and whether it's an injection or a pill. Ozempic and Rybelsus are both semaglutide but they're not the same listing.
4
Write down the tier and rules. Copy the tier, whether prior authorization is needed, and any quantity limit. Snap a screenshot with the date.
5
Ask your prescriber which diagnosis they'll document — and whether it belongs in your Part D plan or the $50 Bridge.

Copy-and-paste phone script. If you’d rather call the number on your card:

“I’m checking coverage before my prescription is sent. My plan is [plan name], the exact medicine and form are [drug and form], and it’s prescribed for [condition]. Is it on my current drug list, what rules apply, and what would I pay at [my pharmacy]?”

Save everything — the screenshot, the date, the reference number they give you. If there’s ever a dispute, that paper trail is gold.

What if my Humana plan won’t cover the GLP-1 I need?

First figure out whether the problem is a missing listing, a restriction, or the wrong claim system. Then you have real moves: ask Humana for a covered alternative, request a coverage exception with your doctor’s support, appeal a denial, or — only if you’ve decided to go around insurance — look at a clearly separate cash-pay FDA-approved option.

Don’t give up after one “no.” Work the list in this order:

Ask Humana for covered alternatives. There may be a similar GLP-1 your plan does list. Talk it through with your prescriber.
Request a coverage exception. Your plan has a formal process — a formulary exception, a tier exception, or a restriction exception. It requires a statement from your prescriber explaining the medical reason it should be approved. You can ask for a faster (expedited) review if waiting could hurt your health.
Appeal a denial. Read the denial reason first, and fix any missing info. Then follow the deadline and steps in your denial notice — your notice states your exact appeal deadline (Part D appeals have a firm window, generally around 60 days to request the first level). Standard decisions usually come back within about 7 days; urgent ones within 72 hours. Include the records and prescriber documentation the plan asks for. Remember: those appeal rights are for your regular plan — a Bridge denial has no appeal, so there the prescriber can only resubmit corrected or added information.

Only after you’ve worked those options should you consider a cash-pay FDA-approved path — and only if you’ve decided not to keep pushing through insurance.

A quick, honest word on compounded medicines.

You’ll see a lot of ads for cheap “compounded semaglutide.” We keep those off this page for a reason. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness, or quality before they’re sold. Humana’s drug guide says some compounded drugs may be Part D eligible, but most are non-formulary and may need an approved coverage decision. They’re a separate topic with separate tradeoffs — don’t confuse them with FDA-approved products on your Humana formulary.

The cash-pay FDA-approved option (only if you’ve decided insurance isn’t your path)

If you’ve hit a wall with coverage and you want an FDA-approved brand without the insurance runaround, a telehealth service that handles the paperwork can be a legitimate route. For this specific situation, we think Ro is the most sensible fit, for a few honest reasons:

Ro carries FDA-approved brands, including Zepbound® (tirzepatide) and Foundayo™ (orforglipron) — no blurring with compounded products.
It matches the manufacturers’ direct pricing on the medication, includes an insurance concierge that handles prior-authorization paperwork, and offers a free coverage checker.
Membership pricing: get started for $39, then as low as $74/month with the annual plan paid upfront (the standard month-to-month membership is $149/month). Medication is billed separately and is not included in the membership price. (We verify pricing before publishing — check Ro’s current membership and medication pricing before you commit.)

But here’s who should NOT click that — and where to go instead. If you qualify for the $50 Medicare Bridge, that’s almost certainly cheaper than any cash-pay plan, so go back up to the Bridge section and start there. Ro membership and its cash-pay medication are separate from the Bridge and are not a Humana benefit. Don’t use Ro’s coverage checker as a substitute for your Humana drug-list lookup or your Bridge eligibility check.

See Ro's current membership and medication pricing (affiliate link) →

Prescription required. A licensed provider determines treatment eligibility and medication choice; membership and medication costs are separate.

orNot sure it’s your best move? Take our matching quiz →

How much will a GLP-1 cost with Humana?

There is no single Humana copay for a GLP-1. Your cost depends on your exact plan, the drug’s tier, your deductible, your pharmacy, and your coverage stage. The Bridge is different: eligible fills are a flat $50 per 30-day supply — but that $50 sits outside your normal Part D benefit and doesn’t count toward your out-of-pocket cap.

Anyone who gives you one price is guessing. Here’s what actually moves your number:

What changes your price	Why it matters
Your exact plan	Different Humana plans place the same drug differently
The tier	Affects your share — but a tier alone isn't a price
Your deductible	You may pay full price until you meet it
Your pharmacy	Preferred vs. standard network pricing can differ
Your coverage stage	What you pay shifts as the year goes on
Extra Help status	Can lower your Part D costs
Bridge vs. Part D	The Bridge is a separate $50 path

Two numbers worth locking in:

The 2026 Part D out-of-pocket cap is $2,100. Humana states this for its 2026 Part D plans. Once your qualifying out-of-pocket costs for covered Part D drugs reach $2,100, your plan pays 100% for covered Part D drugs for the rest of the plan year. That cap rises to $2,400 in 2027. (It applies to covered drugs — not to Bridge fills.)
The Bridge $50 doesn’t touch that cap. It’s flat, it’s separate, and it doesn’t help you reach $2,100 faster.

For your real, personal number, use MyHumana or call the number on your card with your exact drug, form, and pharmacy in hand.

Frequently asked questions about Humana GLP-1 coverage

Humana GLP-1 coverage always comes down to your exact plan, your diagnosis, the drug’s form, and your plan’s rules. These answers cover the most common follow-ups — but your current drug list and your clinician’s decision are what actually control your situation.

Which GLP-1 does Humana prefer?: There is no universal favorite. In the 2026 plans we reviewed, Ozempic and Mounjaro were the most consistently listed for type 2 diabetes. Your exact plan decides, so check yours.
Does Humana cover Ozempic?: Ozempic is on many Humana Medicare plans for type 2 diabetes, usually with prior approval and often a quantity limit. The exact tier and rules vary by plan. It is not covered when used only for weight loss.
Does Humana cover Mounjaro?: Mounjaro is commonly listed for type 2 diabetes with prior approval and quantity limits, varying by plan. It is not a Bridge product, and it is not covered when used only for weight loss.
Does Humana cover Rybelsus?: Rybelsus (oral semaglutide for type 2 diabetes) appears on some Humana plans and not others, so it needs an exact-plan lookup. It is not covered for weight loss, and it is not a Bridge product.
Does Humana cover Trulicity?: Trulicity is a type 2 diabetes GLP-1 that appears on some Humana plans. Coverage, tier, and restrictions vary by plan -- check your specific drug list.
Does Humana cover Wegovy for weight loss?: Not on a standard plan for weight loss by itself. Wegovy injection or tablets may be Part D-coverable for the FDA-approved heart-risk indication if your exact plan lists and approves the form; Wegovy injection -- not the tablets -- may also be coverable for noncirrhotic MASH with F2-F3 fibrosis. For weight-loss-only use, look at the $50 Medicare Bridge.
Does Humana cover Zepbound?: On a standard plan, Zepbound may be Part D-coverable for moderate-to-severe sleep apnea in adults with obesity if your exact plan lists and approves it -- not for weight loss alone. On the Bridge, only the Zepbound KwikPen is included.
Does Humana cover Foundayo?: Foundayo is currently a Medicare Bridge product for eligible weight-loss use. That is not the same as it being on your Humana formulary -- check your plan separately for any other coverage.
Is the Medicare GLP-1 Bridge the same as Humana coverage?: No. Humana runs the processor that handles the claims, but CMS operates the Bridge outside your normal Part D coverage and payment. It is a government program, not a Humana benefit.
Can I appeal a Medicare GLP-1 Bridge denial?: No -- the Bridge has no appeals process. If the request had incorrect or incomplete information, your prescriber can resubmit corrected or added information. This is different from your regular Part D plan, which does have appeal rights.
Are Zepbound KwikPen needles covered by the Bridge?: No. Pen needles are bought separately and generally are not part of the $50 Bridge copay. Ask your pharmacy what they will cost.
How long does a Medicare GLP-1 Bridge approval last?: An approved Bridge request stays valid through December 31, 2027. You generally will not need a new one for refills unless you switch from one covered GLP-1 product to another.
How long do I have to appeal a Humana Part D denial?: Your denial notice states your exact deadline. Part D appeals have a firm window -- generally around 60 days to request the first level of appeal. Standard decisions usually come back within about 7 days; urgent ones within 72 hours. Do not miss the date on your notice.
Does being on Tier 3 guarantee coverage?: No. A listing is a starting point. Prior authorization, quantity limits, a valid diagnosis, and pharmacy rules can still apply.
Can I request a formulary exception?: Yes. If your drug is not listed, you and your prescriber can request a coverage exception with a supporting statement explaining the medical reason. Ask Humana for the exact process.
How often does Humana update its formulary?: Humana posts updates monthly, and coverage can change during the year under Medicare rules. That is exactly why we tell you to check your live plan before you fill.
What if I don't know which Humana plan I have?: Check your ID card, your MyHumana account, your Evidence of Coverage, or call the member number on your card -- before you rely on any general article, including this one.
Are compounded GLP-1s on the Humana formulary?: Some compounded drugs may be Part D eligible, but Humana's drug guide says most are non-formulary and may need an approved coverage decision. Compounded drugs are not FDA-approved, and they are a separate category not covered here.

Still deciding? Start here.

You came here to find the best GLP-1 on Humana formulary. The real answer — the one that actually ends the search — is that it depends on your plan and your diagnosis, and now you have the three doors, the $50 program, and how to check your own numbers. You’ve got what you need to verify your next step with confidence.

Still not sure which GLP-1 program is right for you? Take our free 2-minute matching quiz.

Get my personalized GLP-1 action plan →

No sign-up, no pressure. Matched to your plan type, diagnosis, medication preference, and budget.

Sources (last verified July 2026)

Government / primary

CMS — Medicare GLP-1 Bridge overview: cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
CMS — Medicare GLP-1 Bridge, Information for Providers: cms.gov/medicare/coverage/…/information-providers
CMS — Medicare GLP-1 Bridge, Information for Pharmacies: cms.gov/medicare/coverage/…/information-pharmacies
Medicare.gov — “GLP-1 Drugs for $50 a Month” fact sheet (PDF): medicare.gov/publications/…
Medicare.gov — Drug plan appeals: medicare.gov/…/appeals/drug-plans
FDA — “FDA Approves Treatment for Serious Liver Disease Known as ‘MASH’” (Wegovy): fda.gov/drugs/…
FDA — Human drug compounding, questions and answers: fda.gov/drugs/human-drug-compounding/…

Humana (plan facts — document date and verification date confirmed individually before publishing)

Humana — “Does Medicare Cover Weight-Loss Drugs?”: humana.com/medicare/medicare-resources/…
Humana — Medicare drug list / formulary hub: humana.com/pharmacy/medicare-drug-list
Humana — 2026 Part D drug plans (out-of-pocket cap): humana.com/medicare/part-d-drug-plans

Independent analysis

KFF — “What to Know About the BALANCE Model and the Medicare GLP-1 Bridge”: kff.org/medicare/…
AARP — “Medicare $50 Per Month GLP-1 Weight-Loss Bridge Program”: aarp.org/medicare/glp1-weight-loss-copay-program/

Educational information only. This is not medical or insurance advice. Talk with a licensed healthcare professional and verify your current plan documents before starting, stopping, or changing any treatment or coverage decision.